Dr. William G. Blum
Claim this profileEmory University Hospital/Winship Cancer Institute
Area of expertise
Acute Myelogenous Leukemia
William G. Blum has run 8 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
William G. Blum has run 6 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Emory University Hospital/Winship Cancer Institute
Emory University
Clinical Trials William G. Blum is currently running
CLN-049
for Leukemia and Myelodysplastic Syndrome
CLN-049-001 is a Phase 1, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Recruiting
1 award
Phase 1
MRX-2843
for Leukemia
This is a Phase I, open-label, non-randomized, dose escalation study in adolescents and adults with relapsed/refractory acute myeloid leukemia, acute lymphoblastic leukemia, or mixed phenotype acute leukemia. Patients will receive continuous oral MRX-2843 in 28 day cycles at predefined dose cohorts.
Recruiting
1 award
Phase 1
13 criteria
More about William G. Blum
Clinical Trial Related
4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments William G. Blum has experience with
- Inotuzumab Ozogamicin
- Doxorubicin
- Cytarabine
- Venetoclax
- Azacitidine
- MRX-2843
Breakdown of trials William G. Blum has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Burkitt Lymphoma
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William G. Blum specialize in?
William G. Blum focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved FLT3 positive patients, or patients who are Stage IV.
Is William G. Blum currently recruiting for clinical trials?
Yes, William G. Blum is currently recruiting for 3 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that William G. Blum has studied deeply?
Yes, William G. Blum has studied treatments such as Inotuzumab Ozogamicin, Doxorubicin, Cytarabine.
What is the best way to schedule an appointment with William G. Blum?
Apply for one of the trials that William G. Blum is conducting.
What is the office address of William G. Blum?
The office of William G. Blum is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.